Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitric Oxide in Neonates With Elevated A-aDO2 Gradients Not Requiring Mechanical Ventilation
NCT00732537Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Mar 1999
- Primary completion
- Jun 2005
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of nitric oxide in respiratory failure, persistent pulmonary hypertension of the newborn (PPHN), sponsored by University of Alabama at Birmingham. Started Mar 1999; status: completed.
02
Drugs
nitric oxide
03
Conditions
respiratory failurepersistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on NCT00732537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00732537.